Cargando…

Correction to: Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264066/ https://www.ncbi.nlm.nih.gov/pubmed/37323426 http://dx.doi.org/10.1093/ofid/ofad309

Ejemplares similares

Clinical Outcomes With Extended Versus Intermittent Infusion of Anti-Pseudomonal Beta-Lactams in Patients With Gram-Negative Bacteremia
por: Tran, Nikki N, et al.
Publicado: (2023)

De-Escalating Anti-Pseudomonal β-Lactams
por: Catteeuw, J, et al.
Publicado: (2015)

Rapid Identification of Gram-Negative Bacteremia and Impact on Anti-Pseudomonal Antibiotic Consumption in Combination with Antibiotic Stewardship at a Community-Based Hospital System
por: Box, Maggie, et al.
Publicado: (2017)

Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of resistance to other anti‐pseudomonal β‐lactams?
por: Lodise, Thomas P., et al.
Publicado: (2021)

1822. Clinical Outcomes Associated with Oral Beta-Lactam Therapy versus Oral Fluoroquinolones/TMP-SMX for Uncomplicated Gram-Negative Bacteremia
por: Kaur, Satwinder S, et al.
Publicado: (2022)

203. Evaluating the Impact of Extended-Infusion Beta-Lactam Therapy on Clinical Outcomes and the Subsequent Emergence of Resistance in Adults with Gram-Negative Bloodstream Infections
por: Karaba, Sara M, et al.
Publicado: (2023)

2244. Clinical Outcomes with Extended Infusion (EI) vs. Intermittent Infusion (II) of Cefepime (FEP), Piperacillin/Tazobactam (TZP), and Meropenem (MEM) in Patients with Gram-Negative (GN) Bacteremia
por: Tran, Kieu-Nhi, et al.
Publicado: (2019)

1175. Extended Infusion Beta-lactams in Pediatric Patients with Febrile Neutropenia
por: Nagel, Jerod, et al.
Publicado: (2023)

271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
por: Sinclair, Emily, et al.
Publicado: (2020)

Cefepime extended infusion versus intermittent infusion: Clinical and cost evaluation
por: Khole, Aalok V., et al.
Publicado: (2023)

Resistance to beta-lactams in Gram-negative bacilli: relevance and potential therapeutic alternatives
por: Garcia-Bustos, Víctor, et al.
Publicado: (2022)

Correction to: High rate of extended-spectrum beta-lactamase-producing gram-negative infections and associated mortality in Ethiopia: a systematic review and meta-analysis
por: Tufa, Tafese B., et al.
Publicado: (2020)

220. Effectiveness of Piperacillin/tazobactam Loading Dose for Extended Infusion Dosing Among Patients with Gram-negative Bacteremia (EZ-LD)
por: Patel, Savan, et al.
Publicado: (2023)

1883. Acute Kidney Injury in Patients With Pneumonia on Concomitant Anti-Methicillin-Resistant Staphylococcus aureus and Anti-Pseudomonal β-Lactam Therapy
por: Raux, Brian R, et al.
Publicado: (2018)

P1554: SYSTEMATIC REVIEW OF EXTENDED VERSUS BOLUS INFUSION OF BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS FOR FEBRILE NEUTROPENIA
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

Gram-negative versus Gram-positive bacteremia: what is more alarmin(g)?
por: Alexandraki, Irene, et al.
Publicado: (2010)

239. Outcomes Associated with Empiric Aztreonam Use Compared to Anti-Pseudomonal β-lactams in Patients with Sepsis: An Opportunity for Allergy Stewardship
por: Jaffa, Rupal K, et al.
Publicado: (2020)

Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia
por: Ibrahim, Mohamed M, et al.
Publicado: (2017)

128. Validation of a rapid diagnostics platform for detecting extended-spectrum beta-lactamase resistance in gram negative bacteremia
por: Andrews, Sam, et al.
Publicado: (2023)

Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy
por: FakhriRavari, Alireza, et al.
Publicado: (2022)

Prolonged versus Intermittent Infusion of β-Lactams for the Treatment of Nosocomial Pneumonia: A Meta-Analysis
por: Lal, Ashima, et al.
Publicado: (2016)

Effect of iron chelation on anti-pseudomonal activity of doxycycline
por: Faure, ME, et al.
Publicado: (2021)

Empiric Anti-Pseudomonal β-Lactam Monotherapy Versus Fluoroquinolone Combination Therapy in Patients With Hospital-Acquired Pneumonia: A Multicenter Cohort Study With Propensity Score Matching
por: Baek, Moon Seong, et al.
Publicado: (2023)

Correction to: Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia
por: Walsh, Thomas L., et al.
Publicado: (2021)

656. Prioritizing Gram-Negative Bacteremia (GNB) Cases for Rapid Detection by β-Lactam Resistance (BLR) and Patient Outcomes
por: McCreary, Erin K, et al.
Publicado: (2019)

1022. Is it Time to Re-Evaluate Oral Β-Lactam Antibiotics for Step-Down Therapy of Uncomplicated Gram-Negative Bacteremia?
por: McAlister, Michael, et al.
Publicado: (2019)

Correction: The Mechanism of Heterogeneous Beta-Lactam Resistance in MRSA: Key Role of the Stringent Stress Response
por: Kim, Choonkeun, et al.
Publicado: (2014)

Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia
por: Abe, Ryuzo, et al.
Publicado: (2010)

Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria
por: Nijssen, Saskia, et al.
Publicado: (2009)

Clinical Relevance of Antibiotic Susceptibility Profiles for Screening Gram-negative Microorganisms Resistant to Beta-Lactam Antibiotics
por: Montiel-Riquelme, Francisco, et al.
Publicado: (2020)

Beta-lactam antibiotics in continuous infusion in critically ill patients
por: Jeurissen, Axel, et al.
Publicado: (2010)

248. Evaluation of Continuous versus Intermittent Infusion of Nafcillin in the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Williamson, Julie E, et al.
Publicado: (2023)

1059. Impact of a Syndrome-Based Antimicrobial Stewardship Intervention on Anti-Pseudomonal β-Lactam Use, C. difficile Rates and Cost in an Urban Community Hospital
por: Mena Lora, Alfredo J, et al.
Publicado: (2019)

Efficacy of anti-pseudomonal antibiotics: Need to reconsider the empirical use of cefepime
por: Kotwal, A., et al.
Publicado: (2014)

Correction to: Procalcitonin levels in candidemia versus bacteremia: a systematic review
por: Cortegiani, Andrea, et al.
Publicado: (2019)

Treatment of Gram-negative pneumonia in the critical care setting: is the beta-lactam antibiotic backbone broken beyond repair?
por: Bassetti, Matteo, et al.
Publicado: (2016)

Beta-Lactams Dosing in Critically Ill Patients with Gram-Negative Bacterial Infections: A PK/PD Approach
por: Maguigan, Kelly L., et al.
Publicado: (2021)

Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review
por: Venuti, Francesco, et al.
Publicado: (2023)

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
por: Abdul-Aziz, Mohd H, et al.
Publicado: (2012)

Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
por: Syed, Yahiya Y.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b3i638nt1d4rlb9jkq9ndm7ovr